Global Active Approximators Vascular Closure Device Market Growth 2022-2028
After an angiography, a collagen or suture piece is utilised as a vascular closure device. Vascular closure devices are useful in angiogram leaves an artery puncture. The punctured arteries are sealed using vascular closure devices. The patients' bodies are not negatively affected by the vascular closure devices.
The global market for Active Approximators Vascular Closure Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Active Approximators Vascular Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Active Approximators Vascular Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Active Approximators Vascular Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Active Approximators Vascular Closure Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Active Approximators Vascular Closure Device players cover Terumo Corporation, Abbott, Cardinal Health, Cardiva Medical, Inc and Medtronic, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Active Approximators Vascular Closure Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Active Approximators Vascular Closure Device market, with both quantitative and qualitative data, to help readers understand how the Active Approximators Vascular Closure Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Active Approximators Vascular Closure Device market and forecasts the market size by Type (Passive Approximator and Active Approximator,), by Application (Diagnostic Intervention, Therapeutic Interventions and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Passive Approximator
Active Approximator
Segmentation by application
Diagnostic Intervention
Therapeutic Interventions
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Terumo Corporation
Abbott
Cardinal Health
Cardiva Medical, Inc
Medtronic
Morris Innovative
Teleflex Incorporated
Merit Medical Systems
Vasorum Ltd
TZ Medical
Vivasure Medical Ltd
Tricol Biomedical
Scion Biomedical
Advanced Vascular Dynamics
Marine Polymer Technologies, Inc
Transluminal Technologies
Chapter Introduction
Chapter 1: Scope of Active Approximators Vascular Closure Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Active Approximators Vascular Closure Device market size (sales and revenue) and CAGR, Active Approximators Vascular Closure Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Active Approximators Vascular Closure Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Active Approximators Vascular Closure Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Active Approximators Vascular Closure Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Terumo Corporation, Abbott, Cardinal Health, Cardiva Medical, Inc, Medtronic, Morris Innovative, Teleflex Incorporated, Merit Medical Systems and Vasorum Ltd, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Active Approximators Vascular Closure Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Active Approximators Vascular Closure Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Active Approximators Vascular Closure Device by Country/Region, 2017, 2022 & 2028
2.2 Active Approximators Vascular Closure Device Segment by Type
2.2.1 Passive Approximator
2.2.2 Active Approximator
2.3 Active Approximators Vascular Closure Device Sales by Type
2.3.1 Global Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
2.3.2 Global Active Approximators Vascular Closure Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Active Approximators Vascular Closure Device Sale Price by Type (2017-2022)
2.4 Active Approximators Vascular Closure Device Segment by Application
2.4.1 Diagnostic Intervention
2.4.2 Therapeutic Interventions
2.4.3 Other
2.5 Active Approximators Vascular Closure Device Sales by Application
2.5.1 Global Active Approximators Vascular Closure Device Sale Market Share by Application (2017-2022)
2.5.2 Global Active Approximators Vascular Closure Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Active Approximators Vascular Closure Device Sale Price by Application (2017-2022)
3 Global Active Approximators Vascular Closure Device by Company
3.1 Global Active Approximators Vascular Closure Device Breakdown Data by Company
3.1.1 Global Active Approximators Vascular Closure Device Annual Sales by Company (2020-2022)
3.1.2 Global Active Approximators Vascular Closure Device Sales Market Share by Company (2020-2022)
3.2 Global Active Approximators Vascular Closure Device Annual Revenue by Company (2020-2022)
3.2.1 Global Active Approximators Vascular Closure Device Revenue by Company (2020-2022)
3.2.2 Global Active Approximators Vascular Closure Device Revenue Market Share by Company (2020-2022)
3.3 Global Active Approximators Vascular Closure Device Sale Price by Company
3.4 Key Manufacturers Active Approximators Vascular Closure Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Approximators Vascular Closure Device Product Location Distribution
3.4.2 Players Active Approximators Vascular Closure Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Active Approximators Vascular Closure Device by Geographic Region
4.1 World Historic Active Approximators Vascular Closure Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Active Approximators Vascular Closure Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Active Approximators Vascular Closure Device Annual Revenue by Geographic Region
4.2 World Historic Active Approximators Vascular Closure Device Market Size by Country/Region (2017-2022)
4.2.1 Global Active Approximators Vascular Closure Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Active Approximators Vascular Closure Device Annual Revenue by Country/Region
4.3 Americas Active Approximators Vascular Closure Device Sales Growth
4.4 APAC Active Approximators Vascular Closure Device Sales Growth
4.5 Europe Active Approximators Vascular Closure Device Sales Growth
4.6 Middle East & Africa Active Approximators Vascular Closure Device Sales Growth
5 Americas
5.1 Americas Active Approximators Vascular Closure Device Sales by Country
5.1.1 Americas Active Approximators Vascular Closure Device Sales by Country (2017-2022)
5.1.2 Americas Active Approximators Vascular Closure Device Revenue by Country (2017-2022)
5.2 Americas Active Approximators Vascular Closure Device Sales by Type
5.3 Americas Active Approximators Vascular Closure Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Approximators Vascular Closure Device Sales by Region
6.1.1 APAC Active Approximators Vascular Closure Device Sales by Region (2017-2022)
6.1.2 APAC Active Approximators Vascular Closure Device Revenue by Region (2017-2022)
6.2 APAC Active Approximators Vascular Closure Device Sales by Type
6.3 APAC Active Approximators Vascular Closure Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Active Approximators Vascular Closure Device by Country
7.1.1 Europe Active Approximators Vascular Closure Device Sales by Country (2017-2022)
7.1.2 Europe Active Approximators Vascular Closure Device Revenue by Country (2017-2022)
7.2 Europe Active Approximators Vascular Closure Device Sales by Type
7.3 Europe Active Approximators Vascular Closure Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Active Approximators Vascular Closure Device by Country
8.1.1 Middle East & Africa Active Approximators Vascular Closure Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Active Approximators Vascular Closure Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Active Approximators Vascular Closure Device Sales by Type
8.3 Middle East & Africa Active Approximators Vascular Closure Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Approximators Vascular Closure Device
10.3 Manufacturing Process Analysis of Active Approximators Vascular Closure Device
10.4 Industry Chain Structure of Active Approximators Vascular Closure Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Approximators Vascular Closure Device Distributors
11.3 Active Approximators Vascular Closure Device Customer
12 World Forecast Review for Active Approximators Vascular Closure Device by Geographic Region
12.1 Global Active Approximators Vascular Closure Device Market Size Forecast by Region
12.1.1 Global Active Approximators Vascular Closure Device Forecast by Region (2023-2028)
12.1.2 Global Active Approximators Vascular Closure Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Approximators Vascular Closure Device Forecast by Type
12.7 Global Active Approximators Vascular Closure Device Forecast by Application
13 Key Players Analysis
13.1 Terumo Corporation
13.1.1 Terumo Corporation Company Information
13.1.2 Terumo Corporation Active Approximators Vascular Closure Device Product Offered
13.1.3 Terumo Corporation Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Terumo Corporation Main Business Overview
13.1.5 Terumo Corporation Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Active Approximators Vascular Closure Device Product Offered
13.2.3 Abbott Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Cardinal Health
13.3.1 Cardinal Health Company Information
13.3.2 Cardinal Health Active Approximators Vascular Closure Device Product Offered
13.3.3 Cardinal Health Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cardinal Health Main Business Overview
13.3.5 Cardinal Health Latest Developments
13.4 Cardiva Medical, Inc
13.4.1 Cardiva Medical, Inc Company Information
13.4.2 Cardiva Medical, Inc Active Approximators Vascular Closure Device Product Offered
13.4.3 Cardiva Medical, Inc Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cardiva Medical, Inc Main Business Overview
13.4.5 Cardiva Medical, Inc Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Active Approximators Vascular Closure Device Product Offered
13.5.3 Medtronic Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 Morris Innovative
13.6.1 Morris Innovative Company Information
13.6.2 Morris Innovative Active Approximators Vascular Closure Device Product Offered
13.6.3 Morris Innovative Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Morris Innovative Main Business Overview
13.6.5 Morris Innovative Latest Developments
13.7 Teleflex Incorporated
13.7.1 Teleflex Incorporated Company Information
13.7.2 Teleflex Incorporated Active Approximators Vascular Closure Device Product Offered
13.7.3 Teleflex Incorporated Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teleflex Incorporated Main Business Overview
13.7.5 Teleflex Incorporated Latest Developments
13.8 Merit Medical Systems
13.8.1 Merit Medical Systems Company Information
13.8.2 Merit Medical Systems Active Approximators Vascular Closure Device Product Offered
13.8.3 Merit Medical Systems Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merit Medical Systems Main Business Overview
13.8.5 Merit Medical Systems Latest Developments
13.9 Vasorum Ltd
13.9.1 Vasorum Ltd Company Information
13.9.2 Vasorum Ltd Active Approximators Vascular Closure Device Product Offered
13.9.3 Vasorum Ltd Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vasorum Ltd Main Business Overview
13.9.5 Vasorum Ltd Latest Developments
13.10 TZ Medical
13.10.1 TZ Medical Company Information
13.10.2 TZ Medical Active Approximators Vascular Closure Device Product Offered
13.10.3 TZ Medical Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 TZ Medical Main Business Overview
13.10.5 TZ Medical Latest Developments
13.11 Vivasure Medical Ltd
13.11.1 Vivasure Medical Ltd Company Information
13.11.2 Vivasure Medical Ltd Active Approximators Vascular Closure Device Product Offered
13.11.3 Vivasure Medical Ltd Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Vivasure Medical Ltd Main Business Overview
13.11.5 Vivasure Medical Ltd Latest Developments
13.12 Tricol Biomedical
13.12.1 Tricol Biomedical Company Information
13.12.2 Tricol Biomedical Active Approximators Vascular Closure Device Product Offered
13.12.3 Tricol Biomedical Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Tricol Biomedical Main Business Overview
13.12.5 Tricol Biomedical Latest Developments
13.13 Scion Biomedical
13.13.1 Scion Biomedical Company Information
13.13.2 Scion Biomedical Active Approximators Vascular Closure Device Product Offered
13.13.3 Scion Biomedical Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Scion Biomedical Main Business Overview
13.13.5 Scion Biomedical Latest Developments
13.14 Advanced Vascular Dynamics
13.14.1 Advanced Vascular Dynamics Company Information
13.14.2 Advanced Vascular Dynamics Active Approximators Vascular Closure Device Product Offered
13.14.3 Advanced Vascular Dynamics Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Advanced Vascular Dynamics Main Business Overview
13.14.5 Advanced Vascular Dynamics Latest Developments
13.15 Marine Polymer Technologies, Inc
13.15.1 Marine Polymer Technologies, Inc Company Information
13.15.2 Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Product Offered
13.15.3 Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Marine Polymer Technologies, Inc Main Business Overview
13.15.5 Marine Polymer Technologies, Inc Latest Developments
13.16 Transluminal Technologies
13.16.1 Transluminal Technologies Company Information
13.16.2 Transluminal Technologies Active Approximators Vascular Closure Device Product Offered
13.16.3 Transluminal Technologies Active Approximators Vascular Closure Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Transluminal Technologies Main Business Overview
13.16.5 Transluminal Technologies Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Active Approximators Vascular Closure Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Active Approximators Vascular Closure Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Passive Approximator
Table 4. Major Players of Active Approximator
Table 5. Global Active Approximators Vascular Closure Device Sales by Type (2017-2022) & (K Units)
Table 6. Global Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
Table 7. Global Active Approximators Vascular Closure Device Revenue by Type (2017-2022) & ($ million)
Table 8. Global Active Approximators Vascular Closure Device Revenue Market Share by Type (2017-2022)
Table 9. Global Active Approximators Vascular Closure Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Active Approximators Vascular Closure Device Sales by Application (2017-2022) & (K Units)
Table 11. Global Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Table 12. Global Active Approximators Vascular Closure Device Revenue by Application (2017-2022)
Table 13. Global Active Approximators Vascular Closure Device Revenue Market Share by Application (2017-2022)
Table 14. Global Active Approximators Vascular Closure Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Active Approximators Vascular Closure Device Sales by Company (2020-2022) & (K Units)
Table 16. Global Active Approximators Vascular Closure Device Sales Market Share by Company (2020-2022)
Table 17. Global Active Approximators Vascular Closure Device Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Active Approximators Vascular Closure Device Revenue Market Share by Company (2020-2022)
Table 19. Global Active Approximators Vascular Closure Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Active Approximators Vascular Closure Device Producing Area Distribution and Sales Area
Table 21. Players Active Approximators Vascular Closure Device Products Offered
Table 22. Active Approximators Vascular Closure Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Active Approximators Vascular Closure Device Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Active Approximators Vascular Closure Device Sales Market Share Geographic Region (2017-2022)
Table 27. Global Active Approximators Vascular Closure Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Active Approximators Vascular Closure Device Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Active Approximators Vascular Closure Device Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Active Approximators Vascular Closure Device Sales Market Share by Country/Region (2017-2022)
Table 31. Global Active Approximators Vascular Closure Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Active Approximators Vascular Closure Device Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Active Approximators Vascular Closure Device Sales by Country (2017-2022) & (K Units)
Table 34. Americas Active Approximators Vascular Closure Device Sales Market Share by Country (2017-2022)
Table 35. Americas Active Approximators Vascular Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Active Approximators Vascular Closure Device Revenue Market Share by Country (2017-2022)
Table 37. Americas Active Approximators Vascular Closure Device Sales by Type (2017-2022) & (K Units)
Table 38. Americas Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
Table 39. Americas Active Approximators Vascular Closure Device Sales by Application (2017-2022) & (K Units)
Table 40. Americas Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Table 41. APAC Active Approximators Vascular Closure Device Sales by Region (2017-2022) & (K Units)
Table 42. APAC Active Approximators Vascular Closure Device Sales Market Share by Region (2017-2022)
Table 43. APAC Active Approximators Vascular Closure Device Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Active Approximators Vascular Closure Device Revenue Market Share by Region (2017-2022)
Table 45. APAC Active Approximators Vascular Closure Device Sales by Type (2017-2022) & (K Units)
Table 46. APAC Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
Table 47. APAC Active Approximators Vascular Closure Device Sales by Application (2017-2022) & (K Units)
Table 48. APAC Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Table 49. Europe Active Approximators Vascular Closure Device Sales by Country (2017-2022) & (K Units)
Table 50. Europe Active Approximators Vascular Closure Device Sales Market Share by Country (2017-2022)
Table 51. Europe Active Approximators Vascular Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Active Approximators Vascular Closure Device Revenue Market Share by Country (2017-2022)
Table 53. Europe Active Approximators Vascular Closure Device Sales by Type (2017-2022) & (K Units)
Table 54. Europe Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
Table 55. Europe Active Approximators Vascular Closure Device Sales by Application (2017-2022) & (K Units)
Table 56. Europe Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Active Approximators Vascular Closure Device Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Active Approximators Vascular Closure Device Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Active Approximators Vascular Closure Device Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Active Approximators Vascular Closure Device Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Active Approximators Vascular Closure Device Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Active Approximators Vascular Closure Device Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Active Approximators Vascular Closure Device Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Active Approximators Vascular Closure Device
Table 66. Key Market Challenges & Risks of Active Approximators Vascular Closure Device
Table 67. Key Industry Trends of Active Approximators Vascular Closure Device
Table 68. Active Approximators Vascular Closure Device Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Active Approximators Vascular Closure Device Distributors List
Table 71. Active Approximators Vascular Closure Device Customer List
Table 72. Global Active Approximators Vascular Closure Device Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Active Approximators Vascular Closure Device Sales Market Forecast by Region
Table 74. Global Active Approximators Vascular Closure Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Active Approximators Vascular Closure Device Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Active Approximators Vascular Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Active Approximators Vascular Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Active Approximators Vascular Closure Device Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Active Approximators Vascular Closure Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Active Approximators Vascular Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Active Approximators Vascular Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Active Approximators Vascular Closure Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Active Approximators Vascular Closure Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Active Approximators Vascular Closure Device Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Active Approximators Vascular Closure Device Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Active Approximators Vascular Closure Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Active Approximators Vascular Closure Device Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Active Approximators Vascular Closure Device Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Active Approximators Vascular Closure Device Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Active Approximators Vascular Closure Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Active Approximators Vascular Closure Device Revenue Market Share Forecast by Application (2023-2028)
Table 92. Terumo Corporation Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Terumo Corporation Active Approximators Vascular Closure Device Product Offered
Table 94. Terumo Corporation Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Terumo Corporation Main Business
Table 96. Terumo Corporation Latest Developments
Table 97. Abbott Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Active Approximators Vascular Closure Device Product Offered
Table 99. Abbott Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Abbott Main Business
Table 101. Abbott Latest Developments
Table 102. Cardinal Health Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Cardinal Health Active Approximators Vascular Closure Device Product Offered
Table 104. Cardinal Health Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Cardinal Health Main Business
Table 106. Cardinal Health Latest Developments
Table 107. Cardiva Medical, Inc Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Cardiva Medical, Inc Active Approximators Vascular Closure Device Product Offered
Table 109. Cardiva Medical, Inc Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Cardiva Medical, Inc Main Business
Table 111. Cardiva Medical, Inc Latest Developments
Table 112. Medtronic Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 113. Medtronic Active Approximators Vascular Closure Device Product Offered
Table 114. Medtronic Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Medtronic Main Business
Table 116. Medtronic Latest Developments
Table 117. Morris Innovative Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 118. Morris Innovative Active Approximators Vascular Closure Device Product Offered
Table 119. Morris Innovative Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Morris Innovative Main Business
Table 121. Morris Innovative Latest Developments
Table 122. Teleflex Incorporated Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Teleflex Incorporated Active Approximators Vascular Closure Device Product Offered
Table 124. Teleflex Incorporated Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Teleflex Incorporated Main Business
Table 126. Teleflex Incorporated Latest Developments
Table 127. Merit Medical Systems Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 128. Merit Medical Systems Active Approximators Vascular Closure Device Product Offered
Table 129. Merit Medical Systems Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Merit Medical Systems Main Business
Table 131. Merit Medical Systems Latest Developments
Table 132. Vasorum Ltd Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 133. Vasorum Ltd Active Approximators Vascular Closure Device Product Offered
Table 134. Vasorum Ltd Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Vasorum Ltd Main Business
Table 136. Vasorum Ltd Latest Developments
Table 137. TZ Medical Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 138. TZ Medical Active Approximators Vascular Closure Device Product Offered
Table 139. TZ Medical Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. TZ Medical Main Business
Table 141. TZ Medical Latest Developments
Table 142. Vivasure Medical Ltd Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 143. Vivasure Medical Ltd Active Approximators Vascular Closure Device Product Offered
Table 144. Vivasure Medical Ltd Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Vivasure Medical Ltd Main Business
Table 146. Vivasure Medical Ltd Latest Developments
Table 147. Tricol Biomedical Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 148. Tricol Biomedical Active Approximators Vascular Closure Device Product Offered
Table 149. Tricol Biomedical Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Tricol Biomedical Main Business
Table 151. Tricol Biomedical Latest Developments
Table 152. Scion Biomedical Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 153. Scion Biomedical Active Approximators Vascular Closure Device Product Offered
Table 154. Scion Biomedical Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Scion Biomedical Main Business
Table 156. Scion Biomedical Latest Developments
Table 157. Advanced Vascular Dynamics Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 158. Advanced Vascular Dynamics Active Approximators Vascular Closure Device Product Offered
Table 159. Advanced Vascular Dynamics Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Advanced Vascular Dynamics Main Business
Table 161. Advanced Vascular Dynamics Latest Developments
Table 162. Marine Polymer Technologies, Inc Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 163. Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Product Offered
Table 164. Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Marine Polymer Technologies, Inc Main Business
Table 166. Marine Polymer Technologies, Inc Latest Developments
Table 167. Transluminal Technologies Basic Information, Active Approximators Vascular Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 168. Transluminal Technologies Active Approximators Vascular Closure Device Product Offered
Table 169. Transluminal Technologies Active Approximators Vascular Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Transluminal Technologies Main Business
Table 171. Transluminal Technologies Latest Developments
List of Figures
Figure 1. Picture of Active Approximators Vascular Closure Device
Figure 2. Active Approximators Vascular Closure Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Approximators Vascular Closure Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Active Approximators Vascular Closure Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Active Approximators Vascular Closure Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Passive Approximator
Figure 10. Product Picture of Active Approximator
Figure 11. Global Active Approximators Vascular Closure Device Sales Market Share by Type in 2021
Figure 12. Global Active Approximators Vascular Closure Device Revenue Market Share by Type (2017-2022)
Figure 13. Active Approximators Vascular Closure Device Consumed in Diagnostic Intervention
Figure 14. Global Active Approximators Vascular Closure Device Market: Diagnostic Intervention (2017-2022) & (K Units)
Figure 15. Active Approximators Vascular Closure Device Consumed in Therapeutic Interventions
Figure 16. Global Active Approximators Vascular Closure Device Market: Therapeutic Interventions (2017-2022) & (K Units)
Figure 17. Active Approximators Vascular Closure Device Consumed in Other
Figure 18. Global Active Approximators Vascular Closure Device Market: Other (2017-2022) & (K Units)
Figure 19. Global Active Approximators Vascular Closure Device Sales Market Share by Application (2017-2022)
Figure 20. Global Active Approximators Vascular Closure Device Revenue Market Share by Application in 2021
Figure 21. Active Approximators Vascular Closure Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Active Approximators Vascular Closure Device Revenue Market Share by Company in 2021
Figure 23. Global Active Approximators Vascular Closure Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Active Approximators Vascular Closure Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Active Approximators Vascular Closure Device Sales Market Share by Region (2017-2022)
Figure 26. Global Active Approximators Vascular Closure Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Active Approximators Vascular Closure Device Sales 2017-2022 (K Units)
Figure 28. Americas Active Approximators Vascular Closure Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Active Approximators Vascular Closure Device Sales 2017-2022 (K Units)
Figure 30. APAC Active Approximators Vascular Closure Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Active Approximators Vascular Closure Device Sales 2017-2022 (K Units)
Figure 32. Europe Active Approximators Vascular Closure Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Active Approximators Vascular Closure Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Active Approximators Vascular Closure Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Active Approximators Vascular Closure Device Sales Market Share by Country in 2021
Figure 36. Americas Active Approximators Vascular Closure Device Revenue Market Share by Country in 2021
Figure 37. United States Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Active Approximators Vascular Closure Device Sales Market Share by Region in 2021
Figure 42. APAC Active Approximators Vascular Closure Device Revenue Market Share by Regions in 2021
Figure 43. China Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Active Approximators Vascular Closure Device Sales Market Share by Country in 2021
Figure 50. Europe Active Approximators Vascular Closure Device Revenue Market Share by Country in 2021
Figure 51. Germany Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Active Approximators Vascular Closure Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Active Approximators Vascular Closure Device Revenue Market Share by Country in 2021
Figure 58. Egypt Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Active Approximators Vascular Closure Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Active Approximators Vascular Closure Device in 2021
Figure 64. Manufacturing Process Analysis of Active Approximators Vascular Closure Device
Figure 65. Industry Chain Structure of Active Approximators Vascular Closure Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets